About
Join us at the 30th American Society of Cell and Gene Therapy (ASGCT) Annual Meeting from May 11–13 at the Thomas M. Menino Convention & Exhibition Center in Boston, MA. We are thrilled to return as a sponsor for this year’s event, which explores the latest advancements in the cell and gene therapy industry. Book a meeting with our team to connect in person and discuss your project needs.
Meet our experts at booth 1331
Sebastien Ribault, PhD
Chief Business Officer
Mark Marrano
Director, Business Development
Lisa Parenteau
Director, Business Development
Shyamali Mandal, PhD
Director, Business Development
Workshop participation
Workshop: Automation in CGT manufacturing: From production to QC
Session: Automation of Cell Based Assays-QC Implementation Strategies and Challenges
Presenter: Dr. André Raposo, Senior Director, Innovation
Date: Monday, May 11
Time: 4:04 pm-4:34 pm
Room: 162AB
Industry-sponsored symposium
Title: Beyond the Buzzword: What ‘Commercial-Ready’ Really Means in Cell and Gene Therapy
Presenter: Kelly Walsh, Senior Scientist, Downstream and Drug Product
Date: Thursday, May 14 Time: 3:30-4:00 pm EDT
Room: 109AB
Oral presentations
Title: Beyond 90% Full: Expanding the Role of Anion Exchange Chromatography in AAV Product Quality Control
Presenter: Luke Mustich, Scientist I, Downstream
Date: Tuesday, May 12
Time: 11:00-11:15 am
Room: 109AB
Session: AAV Downstream Manufacturing
Title: Just Because You Can, Doesn’t Mean You Should: Why Higher Upstream Titer May Not Be Best for Your AAV Process
Presenter: Richard Gilmore, Senior Scientist I, Upstream
Date: Thursday, May 14
Time: 11:30-11:45 am
Room: 205ABC
Session: AAV Transfection Improvements- Scaling and Titers
Title: Justifying a Pathway to Reduced Replication-Competent Lentivirus (RCL) Testing – Adding the Empirical to the Theoretical
Presenter: Daniel Farley, Senior Director, PRG
Date: Thursday, May 14
Time: 3:30-3:45 pm
Room: 257AB
Session: Vector Manufacturing and Analytics
Posters
Title: Enhancing AAV Production Yield Utilizing An Engineered Adenoviral Helper Plasmid
Presenter: Annie Adusei, Research Associate II, Process Development
Date: Wednesday, May 13
Time: 5:00-6:30 pm
Title: PacBio Sequencing Offers Valuable Insight for AAV Vector Design and Process Development
Presenter: Dr. Dimpal Lata, Scientist II
Date: Wednesday, May 13
Time: 5:00-6:30 pm
Title: Evaluating the Intermediate Hold Stability of AAV8 for Manufacturing Suitability
Presenter: Nishadi Gamage, Research Associate II, Downstream and Drug Product Development
Date: Wednesday, May 13
Time: 5:00-6:30 pm
Title: Maximizing AAV Recovery on Affinity Capture: Yield Gains or Quality Compromise?
Presenter: Thomas Thiers, Scientist II
Date: Wednesday, May 13
Time: 5:00-6:30 pm
Title: AAV Vector Production is Driven by a Small Fraction of Transfected Cells
Presenter: Katrina Costa-Grant, Scientist I
Date: Wednesday, May 13
Time: 5:00-6:30 pm
Title: AAV Aggregation: Ultrafiltration/diafiltration as a Stress Step in AAV Manufacturing
Presenter: Danny Lassiter, Research Associate II, Process Development
Date: Thursday, May 14
Time: 5:00-6:30 pm
Title: Development & Scale Up of Next Generation LV Batch Process Demonstrating Increased Productivity & Enhanced Purity
Presenter: Dr. Ciaran Lamont, Prinicipal Scientist
Date: Thursday, May 14
Time: 5:00-6:30 pm